In 2022, South Korean pharmaceutical company Yuhan's prescription (ethical-the-counter, ETC) drugs sector made up around 1.1 trillion South Korean won of the company's total sales revenue. This made it their most successful business sector by far, followed by over-the-counter (OTC) drugs sector at about 236.2 billion won in revenue.
Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Largest nonprescription pharmaceutical companies in Norway 2021, by market share
- Premium Statistic Sales revenue distribution Yuhan 2022, by sector
About the region
10
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Yuhan-Kimberly's net profit 2016-2019
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
Selected statistics
10
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Premium Statistic Colombia: pharmaceutical establishments 2014-2018
- Premium Statistic Italy: pharmaceutical marketing channels according to GPs
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Industry turnover for leading pharmaceuticals German 2017
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Salaries among U.S. pharmaceutical sales representatives 2016-2018
- Basic Statistic Value of pharmaceutical sales in Luxembourg 2003-2022
Related statistics
10
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
Yuhan. (March 15, 2023). Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/
Yuhan. "Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won)." Chart. March 15, 2023. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/
Yuhan. (2023). Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/
Yuhan. "Sales Revenue of Yuhan Co., Ltd. in 2022, by Business Sector (in Billion South Korean Won)." Statista, Statista Inc., 15 Mar 2023, https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/
Yuhan, Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won) Statista, https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/ (last visited April 19, 2024)
Sales revenue of Yuhan Co., Ltd. in 2022, by business sector (in billion South Korean won) [Graph], Yuhan, March 15, 2023. [Online]. Available: https://www.statista.com/statistics/975411/yuhan-sales-revenue-by-sector/